<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Craig EJ</submitter><funding>NCATS NIH HHS</funding><funding>NIDA NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>102005</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8854443</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>78</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Tobacco cessation treatment for cancer patients is essential to providing comprehensive oncologic care. We have implemented a point of care tobacco treatment care model enabled by electronic health record (EHR) modifications in a comprehensive cancer center. Data are needed on the sustainability of both reach of treatment and effectiveness over time, including the COVID-19 pandemic.&lt;h4>Methods&lt;/h4>Using EHR data from the pre-implementation (P: 5 months) and post-implementation periods (6 month-blocks, T1-T5 for a total of 30 months), we compared two primary outcomes: 1) reach of treatment among those smoking and 2) effectiveness assessed by smoking cessation among those smoking in the subsequent 6 month period. We analyzed the data using generalized estimation equation r</pubmed_abstract><journal>Cancer epidemiology</journal><pubmed_title>Point of care tobacco treatment sustains during COVID-19, a global pandemic.</pubmed_title><pmcid>PMC8854443</pmcid><funding_grant_id>P01 CA180945</funding_grant_id><funding_grant_id>P30 CA091842</funding_grant_id><funding_grant_id>R34 DA052928</funding_grant_id><funding_grant_id>K12 DA041449</funding_grant_id><funding_grant_id>UL1 TR002345</funding_grant_id><funding_grant_id>P50 CA244431</funding_grant_id><funding_grant_id>P30 DK092950</funding_grant_id><funding_grant_id>R35 CA197573</funding_grant_id><funding_grant_id>R01 DA038076</funding_grant_id><pubmed_authors>Pham G</pubmed_authors><pubmed_authors>Ramsey AT</pubmed_authors><pubmed_authors>Chen LS</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Craig EJ</pubmed_authors><pubmed_authors>Luke DA</pubmed_authors><pubmed_authors>Bierut LJ</pubmed_authors><pubmed_authors>Goldberg P</pubmed_authors><pubmed_authors>Baker TB</pubmed_authors><pubmed_authors>Malone S</pubmed_authors><pubmed_authors>Govindan R</pubmed_authors><pubmed_authors>James AS</pubmed_authors><pubmed_authors>Smock N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Point of care tobacco treatment sustains during COVID-19, a global pandemic.</name><description>&lt;h4>Background&lt;/h4>Tobacco cessation treatment for cancer patients is essential to providing comprehensive oncologic care. We have implemented a point of care tobacco treatment care model enabled by electronic health record (EHR) modifications in a comprehensive cancer center. Data are needed on the sustainability of both reach of treatment and effectiveness over time, including the COVID-19 pandemic.&lt;h4>Methods&lt;/h4>Using EHR data from the pre-implementation (P: 5 months) and post-implementation periods (6 month-blocks, T1-T5 for a total of 30 months), we compared two primary outcomes: 1) reach of treatment among those smoking and 2) effectiveness assessed by smoking cessation among those smoking in the subsequent 6 month period. We analyzed the data using generalized estimation equation r</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-18T12:18:04.391Z</modification><creation>2025-04-06T21:51:40.421Z</creation></dates><accession>S-EPMC8854443</accession><cross_references><pubmed>34446379</pubmed><doi>10.1016/j.canep.2021.102005</doi></cross_references></HashMap>